key: cord-0862206-fb28grlv authors: Girolamo, Raffaella Di; Khalil, Asma; Alameddine, Sara; D'Angelo, Emanuela; Galliani, Carmen; Matarrelli, Barbara; Buca, Danilo; Liberati, Marco; Rizzo, Giuseppe; D'Antonio, Francesco title: Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis date: 2021-08-21 journal: Am J Obstet Gynecol MFM DOI: 10.1016/j.ajogmf.2021.100468 sha: b7a0ed012f1b385aa992c8bf423541ac7ae64eac doc_id: 862206 cord_uid: fb28grlv OBJECTIVES: : To report the spectrum of placental pathology findings in pregnancies complicated by SARS-CoV-2 infection. METHODS: : MEDLINE, EMBASE, Google Scholar and the Web of Science databases were searched up to August 11(th), 2021. Histopathological anomalies included maternal vascular malperfusion (MVM), fetal vascular malperfusion (FVM), acute inflammatory pathology (AIP), chronic inflammatory pathology (CIP), increased perivillous fibrin and intervillous thrombosis. Sub-analyses including only symptomatic women and high-risk pregnancies were also performed. Histopathological analysis of the placenta included gross examination, histopathology on hematoxylin and eosin (H&E), immunohistochemistry (IHC), fluorescence in-situ hybridization (FISH), qRT-PCR on placental tissue, and transmission electron microscope (TEM). Random-effect meta-analyses were used to analyze the data. RESULTS: : Fifty-seven studies (1009 pregnancies) were included. MVM was reported in 31.4% (95% CI 21.0-42.8) of placentas, while FVM was observed in 26.9% of cases (95% CI 19.2-35.4). AIP and CIP were reported in 22.6% (95% CI 16.8-28.9) and 26.2% (95% CI 18.9-34.2) of cases, respectively. Increased perivillous fibrin was observed in 32.7% (95% CI 24.1-42.0) of placentas undergoing histopathological analysis, while intervillous thrombosis were observed in 14.6% (95% CI 10.6-21.8) of cases. Other placental findings, including either basal plate with attached myometrial fibers, microscopic accretism, villous edema, increased circulating nucleated Red Blood Cells or membranes with hemorrhage were reported in 38% (95% CI 28.5-48.0) of cases, while only 17.4% (95% CI 10.9-25.0) did not present any abnormal histological findings. Sub-analyses according to maternal symptoms due to SARS-CoV-2 infection or the presence of a high-risk pregnancy showed similar distribution of the different histopathological anomalies to that reported in the main analysis. The risk of placental histopathological anomalies was also higher when considering only case-control studies comparing women with SARS-CoV-2 infection with healthy controls. CONCLUSIONS: : A significant proportion of placentas where SARS-CoV-2 occurred during pregnancy shows histopathological findings suggesting placental hypoperfusion and inflammation. Future multicenter prospective blinded studies are needed to correlate these placental lesions with pregnancy outcomes. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection spread towards the end of 2019 and nowadays is still a major issue of Public Health, with new cases of infection, hospitalization, admission to Intensive Care Unit (ICU) and even deaths increasing daily worldwide. 1 Pregnancy has been reported to be an independent risk factor for adverse outcome in women with SARS-CoV-2 infection, especially if other co-morbidities, such as diabetes or preeclampsia co-exist. The peculiar changes occurring in the cardiorespiratory system during pregnancy may be partially responsible of the increased burden of maternal morbidities observed in these women when compared to the non-pregnant general population. [2] [3] [4] [5] Currently, although vaccinal programs are opened to pregnant women, there are still reports of a poor acceptance rate in this category of patients. 6, 7 Indeed, SARS-CoV-2 infection has been reported to potentially affect the placenta. 8 Several reports suggest an increased risk of placental lesions due to hypoperfusion and inflammation in women with SARS-CoV-2 infection. The potential association between SARS-CoV-2 and impaired placental function is crucial because it might lead to fetal decompensation and increased risk of perinatal mortality and morbidity. [66] [67] Despite this, the occurrence of placental histopathological abnormalities in pregnancies complicated by SARS-CoV-2 infection is yet to be fully explored. The small sample size of previously published studies, heterogeneity in outcome assessment and inclusion criteria do not allow to extrapolate an objective evidence on the actual risk of placental inflammatory and vascular anomalies in women with SARS-CoV-2 infection during pregnancy. 8, 55 The aim of this systematic review was to quantify the prevalence of placental histopathological abnormalities in women with SARS-CoV-2 infection in pregnancy. This systematic review was performed according to an a-priori designed protocol and recommended for systematic reviews and meta-analysis. MEDLINE, EMBASE, Google Scholar and the Web of Science databases were searched electronically up to August 11 th , 2021 using the following search terms (as words in the title/abstract), utilizing combinations of the relevant medical subject heading (MeSH) terms, keywords and word variants for "Histopathology", "Placenta" and "COVID-19. The search and selection criteria were restricted to English language. Reference lists of relevant articles and reviews were hand searched for additional reports. PRISMA guidelines were followed. 68 The histopathological abnormalities assessed were divided in the following sub-categories, Three authors (RDG, SA, CG) reviewed all abstracts independently. Agreement regarding potential relevance was reached by consensus. Full text copies of those papers were obtained, and the same three reviewers independently extracted relevant data regarding study characteristics, placental pathological findings and pregnancy outcome. Inconsistencies were discussed by the reviewers and consensus reached by discussion with the senior authors (ML, FDA). Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale (NOS) for case-control or cohort studies. According to NOS, each study is judged on three broad perspectives: the selection of the study groups, the comparability of the groups and the ascertainment of outcome of interest. Assessment of the selection of a study includes the evaluation of the representativeness of the exposed cohort, selection of the non-exposed cohort, ascertainment of exposure and the demonstration that the outcome of interest was not present at the start of study. Assessment of the comparability of the study includes the evaluation of the comparability of cohorts based on the design or analysis. Finally, the ascertainment of the outcome of interest includes the evaluation of the type of the assessment of the outcome of interest, its length and the adequacy of follow up. According to NOS, a study can be awarded a maximum of one star for each numbered item within the Selection and Outcome categories. A maximum of two stars can be given for Comparability. [70] [71] Case series were evaluated with a modified version of NOS, 72 which is based on 8 questions in the domains of selection, ascertainment, causality and reporting. Although a formal score could be assigned giving a binary response to each question, the numeric representation of methodological quality was not considered appropriate as recommended, and the overall final judgment was made based on questions 1, 2, 3, 7 and 8, which were deemed most critical in this specific clinical scenario. We used meta-analyses of proportions to combine data and reported pooled proportions and their 95% confidence intervals (CI). Then we compared the risk of the different histopathological anomalies in women with SARS-CoV-2 infection in pregnancy compared to healthy controls and expressed the results as odd ratio (OR) with their 95% confidence intervals (CI). Between-study heterogeneity was explored using the I2 statistic, which represents the percentage of between-study variation that is due to heterogeneity rather than chance. A value of 0% indicates that no heterogeneity was observed, whereas values >50% are associated with substantial heterogeneity. Due to the clinical heterogeneity among studies, a random effects model was used for all metaanalyses. Egger's test was used to assess potential publication bias and funnel plots were created for visual inspection. Tests for funnel plot asymmetry were not used when the total number of publications included for each outcome was less than 10, as the tests lack power to detect real asymmetry in this scenario. The analysis was performed using Stats direct 3.0.171 (Stats Direct Ltd) and Revman 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, 2014) statistical software. We identified 153 articles, 81 of which were assessed with respect to their eligibility for inclusion and 57 studies were included in the systematic review (Table 1, Figure 1 ). These 57 studies included 1009 pregnancies complicated by SARS-CoV-2 infection. Complete histopathological analysis of the placenta was reported in 896 cases ( Table 1 ). The results of the quality assessment of the included studies using NOS and NOS modified scale are presented in Tables 2 and 3 . The included studies showed an overall good score regarding the selection and comparability of the study groups, and for ascertainment of the outcome of interest. The main weaknesses of these studies were their smalls sample size, lack of blinding towards the presence of infection and heterogeneity of histopathological analyses reported among the included studies. (Table 5) . Assessment of the actual risk of developing histopathological anomalies was assessed including only case-control studies comparing women with SARS-CoV-2 infection in pregnancy with healthy controls. Unfortunately, the analysis was affected by the smaller number of studies and even smaller number of cases included compared to the proportion meta-analysis, thus potentially representing a source of bias. Furthermore, we could not stratify the analysis according to the presence of maternal symptoms or high-risk pregnancy. Overall, women with SARS-CoV-2 infection in pregnancy had a higher risk of fetal vascular malperfusion Table 6 ). The findings from this systematic review show that a large proportion of pregnancies complicated by SARS-CoV-2 infection presents placental histopathological abnormalities consistent with placental inflammation and hypoperfusion, while only about 17.4% of these pregnancies did not show any placental anomalies. Sub-group analyses according to the presence of maternal symptoms or high-risk pregnancy showed similar results with the large majority of placenta from women with SARS-CoV-2 infection in pregnancy. The Maternal vascular hypoperfusion is potentially associated with higher risk of impaired placental function, growth restriction, and stillbirth. 77 In the present systematic review, we reported a high incidence of placental lesions suggesting hypoperfusion and inflammation, thus questioning whether these women should undergo additional scans during pregnancy. Although sub-group analysis according to the severity of the disease and gestational age at infection could not be performed, it might be reasonable to offer women recovered form SARS-CoV-2 infection an additional growth scan in the third trimester, in order to rule out the possibility of reduced fetal growth due to impaired placental function, and therefore, reassure the parents. More importantly, additional ultrasound scans throughout pregnancy might be required in women presenting with objective risk factors for growth restriction, such as a previous complicated pregnancy, abnormal placental biomarkers or increased pulsatility index in the uterine arteries, because in these women SARS-CoV-2 infection may worsen an already compromised placenta. Thorough literature search aimed at including all potentially relevant studies, multitude of histopathological anomalies and the large numbers of included cases 9-65 represent the main 11 17 strengths of the present systematic review. The retrospective design of most of the included studies, small sample size, and heterogeneity in histopathological anomalies observed, are the main limitations of this systematic review. Furthermore, in none of the study, the pathologists performing the analysis of the placenta were blinded to maternal infection status. Another major limitation of the present systematic review was that we consider only macroscopic histopathological anomalies of the placenta, and we did not consider the single pathological diagnoses contained within these categories. Finally, sub-group analysis considering only case control studies was also affected by a small number of studies. Despite these limitations, the present systematic review represents the most comprehensive up-to-date critical appraisal on the occurrence of histopathological anomalies in placentas from women who had SARS-CoV-2 infection in pregnancy. for cohort studies; a study can be awarded a maximum of one star for each numbered item within the Selection and Outcome categories. A maximum of two stars can be given for Comparability. Table 3 . Tool for evaluating the methodological quality of case reports and case series. Table 5 . Pooled proportions (with their 95% CI) for the different histopathological anomalies detected in placentas from symptomatic women affected by SARS-CoV-2 infection in pregnancy and in those with high-risk pregnancies. Studies (n) Cases (n/N) Pooled proportions (95% CI) COVID-19: Virology, biology and novel laboratory diagnosis Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19 On the behalf of the World Association of Perinatal Medicine working group on coronavirus disease 2019. Maternal and perinatal outcomes in high compared to low risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection (phase 2): the World Association of Perinatal Medicine working group on coronavirus disease 2019 Proposal for radiologic diagnosis and follow-up of COVID-19 in pregnant women Women perception of SARS-CoV-2 vaccination during pregnancy and subsequent maternal anxiety: a prospective observational study Pregnant women's perspectives on severe acute respiratory syndrome coronavirus 2 vaccine A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy Considerations on COVID-19 pregnancy: a cases series during outbreak in Bergamo Province Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia Zhejiang Da Xue Xue Bao Yi Xue Ban Histological characterization of placenta in COVID19 pregnant women SARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface. medRxiv Trophoblast damage with acute and chronic intervillositis: disruption of the placental barrier by severe acute respiratory syndrome coronavirus 2 SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta Perinatal Transmission of 2019 Coronavirus Disease-Associated Severe Acute Respiratory Syndrome Coronavirus 2: Should We Worry? Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19 Placental pathology of the third trimester pregnant women from COVID-19 Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection Case series of 20 pregnant women with 2019 novel coronavirus disease in Wuhan Histopathology of Third Trimester Placenta from SARS-CoV-2-Positive Women Maternal, placental and neonatal outcomes after asymptomatic SARS-CoV-2 infection in the first trimester of pregnancy: A case report. Case Rep Womens Health SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers SARS-CoV-2 infection of the placenta Placental SARS-CoV-2 in a pregnant woman with mild COVID-19 disease Placental SARS-CoV-2 in a Patient with Mild COVID-19 Disease Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Maternal and perinatal outcomes and placental pathologic examination of 29 SARS-CoV-2 infected patients in the third trimester of gestation Chronic Histiocytic Intervillositis With Trophoblast Necrosis Is a Risk Factor Associated With Placental Infection From Coronavirus Disease 2019 (COVID-19) and Intrauterine Maternal-Fetal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Live-Born and Stillborn Infants Placental Pathology in COVID-19 Placental Pathology in COVID-19: Case Series in a Community Hospital Setting. Cureus Intrauterine Transmission of SARS-COV-2 Infection in a Preterm Infant Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads Placental pathology in COVID-19 affected pregnant women: A prospective case-control study Fetal and placental infection with SARS-CoV-2 in early pregnancy Transplacental transmission of SARS-CoV-2 infection A Case Report of Neonatal 2019 Coronavirus Disease in China A Case of 2019 Novel Coronavirus in a Pregnant Woman With Preterm Delivery Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID--19 Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study Effect of SARS-CoV-2 infection during the second half of pregnancy on fetal growth and hemodynamics: A prospective study PRISMA harms checklist: improving harms reporting in systematic reviews Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement Systematic reviews: CRD's guidance for undertaking reviews in health care Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments Methodological quality and synthesis of case series and case reports Being pregnant in the COVID-19 pandemic: effects on the placenta in all I 2 (%) Acknowledgements: none. Algarroba 9 2020 USA Case report 1